These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

978 related articles for article (PubMed ID: 22930785)

  • 1. Prediction of occult central lymph node metastasis in papillary thyroid carcinoma by preoperative BRAF analysis using fine-needle aspiration biopsy: a prospective study.
    Joo JY; Park JY; Yoon YH; Choi B; Kim JM; Jo YS; Shong M; Koo BS
    J Clin Endocrinol Metab; 2012 Nov; 97(11):3996-4003. PubMed ID: 22930785
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BRAF V600E mutation independently predicts central compartment lymph node metastasis in patients with papillary thyroid cancer.
    Howell GM; Nikiforova MN; Carty SE; Armstrong MJ; Hodak SP; Stang MT; McCoy KL; Nikiforov YE; Yip L
    Ann Surg Oncol; 2013 Jan; 20(1):47-52. PubMed ID: 22941165
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of molecular markers and tumor histological type in central lymph node metastasis of papillary thyroid carcinoma.
    Paulson L; Shindo M; Schuff K; Corless C
    Arch Otolaryngol Head Neck Surg; 2012 Jan; 138(1):44-9. PubMed ID: 22249628
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preoperative BRAF mutation is predictive of occult contralateral carcinoma in patients with unilateral papillary thyroid microcarcinoma.
    Zhou YL; Zhang W; Gao EL; Dai XX; Yang H; Zhang XH; Wang OC
    Asian Pac J Cancer Prev; 2012; 13(4):1267-72. PubMed ID: 22799316
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictive factors for ipsilateral or contralateral central lymph node metastasis in unilateral papillary thyroid carcinoma.
    Koo BS; Choi EC; Yoon YH; Kim DH; Kim EH; Lim YC
    Ann Surg; 2009 May; 249(5):840-4. PubMed ID: 19387316
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preoperative BRAF mutation has different predictive values for lymph node metastasis according to tumor size.
    So YK; Son YI; Park JY; Baek CH; Jeong HS; Chung MK
    Otolaryngol Head Neck Surg; 2011 Sep; 145(3):422-7. PubMed ID: 21750338
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The BRAF mutation is predictive of aggressive clinicopathological characteristics in papillary thyroid microcarcinoma.
    Lin KL; Wang OC; Zhang XH; Dai XX; Hu XQ; Qu JM
    Ann Surg Oncol; 2010 Dec; 17(12):3294-300. PubMed ID: 20953721
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BRAF V600E mutation: Differential impact on central lymph node metastasis by tumor size in papillary thyroid carcinoma.
    Kim SK; Lee JH; Woo JW; Park I; Choe JH; Kim JH; Kim JS
    Head Neck; 2016 Apr; 38 Suppl 1():E1203-9. PubMed ID: 26268700
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does BRAF V600E mutation predict aggressive features in papillary thyroid cancer? Results from four endocrine surgery centers.
    Li C; Aragon Han P; Lee KC; Lee LC; Fox AC; Beninato T; Thiess M; Dy BM; Sebo TJ; Thompson GB; Grant CS; Giordano TJ; Gauger PG; Doherty GM; Fahey TJ; Bishop J; Eshleman JR; Umbricht CB; Schneider EB; Zeiger MA
    J Clin Endocrinol Metab; 2013 Sep; 98(9):3702-12. PubMed ID: 23969188
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BRAF mutation testing of thyroid fine-needle aspiration biopsy specimens for preoperative risk stratification in papillary thyroid cancer.
    Xing M; Clark D; Guan H; Ji M; Dackiw A; Carson KA; Kim M; Tufaro A; Ladenson P; Zeiger M; Tufano R
    J Clin Oncol; 2009 Jun; 27(18):2977-82. PubMed ID: 19414674
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of BRAF V600E Mutation and MicroRNA Expression with Central Lymph Node Metastases in Papillary Thyroid Cancer: A Prospective Study from Four Endocrine Surgery Centers.
    Han PA; Kim HS; Cho S; Fazeli R; Najafian A; Khawaja H; McAlexander M; Dy B; Sorensen M; Aronova A; Sebo TJ; Giordano TJ; Fahey TJ; Thompson GB; Gauger PG; Somervell H; Bishop JA; Eshleman JR; Schneider EB; Witwer KW; Umbricht CB; Zeiger MA
    Thyroid; 2016 Apr; 26(4):532-42. PubMed ID: 26950846
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The thyroid imaging reporting and data system on US, but not the BRAFV600E mutation in fine-needle aspirates, is associated with lateral lymph node metastasis in PTC.
    Park VY; Kim EK; Moon HJ; Yoon JH; Kwak JY
    Medicine (Baltimore); 2016 Jul; 95(29):e4292. PubMed ID: 27442672
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduction of false-negative papillary thyroid carcinomas by the routine analysis of BRAF(T1799A) mutation on fine-needle aspiration biopsy specimens: a prospective study of 814 thyroid FNAB patients.
    Cañadas-Garre M; Becerra-Massare P; López de la Torre-Casares M; Villar-del Moral J; Céspedes-Mas S; Vílchez-Joya R; Muros-de Fuentes T; García-Calvente C; Piédrola-Maroto G; López-Nevot MA; Montes-Ramírez R; Llamas-Elvira JM
    Ann Surg; 2012 May; 255(5):986-92. PubMed ID: 22504197
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The synergic effect of BRAF
    Qu HJ; Qu XY; Hu Z; Lin Y; Wang JR; Zheng CF; Tan Z
    Endocr J; 2018 Jan; 65(1):113-120. PubMed ID: 29070763
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimizing surgical treatment of papillary thyroid carcinoma associated with BRAF mutation.
    Yip L; Nikiforova MN; Carty SE; Yim JH; Stang MT; Tublin MJ; Lebeau SO; Hodak SP; Ogilvie JB; Nikiforov YE
    Surgery; 2009 Dec; 146(6):1215-23. PubMed ID: 19958951
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is BRAF mutation associated with lymph node metastasis in patients with papillary thyroid cancer?
    Lee KC; Li C; Schneider EB; Wang Y; Somervell H; Krafft M; Umbricht CB; Zeiger MA
    Surgery; 2012 Dec; 152(6):977-83. PubMed ID: 23062653
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of BRAF V600E mutation as an indicator of the extent of thyroidectomy and lymph node dissection in conventional papillary thyroid carcinoma.
    Kim SK; Woo JW; Lee JH; Park I; Choe JH; Kim JH; Kim JS
    Surgery; 2015 Dec; 158(6):1500-11. PubMed ID: 26120069
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytomorphological factors and BRAF mutation predicting risk of lymph node metastasis in preoperative liquid-based fine needle aspirations of papillary thyroid carcinoma.
    Chung SY; Lee JS; Lee H; Park SH; Kim SJ; Ryu HS
    Acta Cytol; 2013; 57(3):252-8. PubMed ID: 23636013
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BRAF: a tool in the decision to perform elective neck dissection?
    Dutenhefner SE; Marui S; Santos AB; de Lima EU; Inoue M; Neto JS; Shiang C; Fukushima JT; Cernea CR; Friguglietti CU
    Thyroid; 2013 Dec; 23(12):1541-6. PubMed ID: 23186006
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation between US-FNAC with BRAF V600E Mutation Analysis and Central Neck Lymph Node Metastasis in cN0 Papillary Thyroid Cancer.
    Li R; Hao J; Zhu Z; Qiao X; Wang L; Zhou Z
    Biomed Res Int; 2021; 2021():9937742. PubMed ID: 34307677
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 49.